Zila Inc. (Nasdaq GM: ZILA) has closed on the sale of the assets of its Zila Swab Technologies, Inc. or "IST" subsidiary to Great Midwest Packaging, LLC. IST manufactures and markets plastic molded products that are used in various specialty packaging applications. The sale is consistent with Zila's strategy of focusing its business on cancer detection technologies and divesting non-core assets. About Zila Zila, Inc., headquartered in Phoenix, is an innovator in preventive healthcare technologies and products, focusing on enhanced body defense and the detection of pre-disease states. Zila has three business units: -- Zila Biotechnology, a research, development and licensing business specializing in pre-cancer/cancer detection through its patented Zila Tolonium Chloride and OraTest(R) technologies. -- Zila Pharmaceuticals, a manufacturer and marketer of products to promote oral health and prevent oral disease, including ViziLite(R) Plus oral examination kits and Peridex(R) prescription periodontal rinse. -- Zila Nutraceuticals, manufacturer and marketer of Ester-C(R) and Ester-E(R), branded, highly effective forms of Advanced Protection vitamins C and E. For more information about Zila, visit www.zila.com.
Zila (NASDAQ:ZILA)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Zila Charts.
Zila (NASDAQ:ZILA)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Zila Charts.